Viewing Study NCT04541433


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-01-09 @ 1:59 AM
Study NCT ID: NCT04541433
Status: COMPLETED
Last Update Posted: 2025-08-07
First Post: 2020-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast Cancer
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ER+ HER2- Advanced Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None Phase 1 View
None Safety View
None Tolerability View
None Pharmacokinetics View
None ER Positive View
None HER2 Negative View
None Advanced Breast Cancer View